Concepedia
PubMed · 2013 · 61 citations · 10 references
DEBIRI is a well-tolerated treatment option that can be used safely in the palliative treatment of hepatic metastases from CRC.
10
<i>K-ras</i> Mutations and Benefit from Cetuximab in Advanced Colorectal Cancer
Christos S. Karapetis, Shirin Khambata‐Ford, Derek J. Jonker et al. · New England Journal of Medicine · 2008 · 3.6K citations
Improved Survival in Metastatic Colorectal Cancer Is Associated With Adoption of Hepatic Resection and Improved Chemotherapy
Scott Kopetz, George J. Chang, Michael J. Overman et al. · Journal of Clinical Oncology · 2009 · 1.3K citations · Full text
Simultaneous Resections of Colorectal Cancer and Synchronous Liver Metastases: A Multi-institutional Analysis
Srinevas K. Reddy, Timothy M. Pawlik, Daria Zorzi et al. · Annals of Surgical Oncology · 2007 · 419 citations
Surgical Oncology, Hepatology, Gastrointestinal Oncology +11
Intra-arterial infusion of irinotecan-loaded drug-eluting beads (DEBIRI) versus intravenous therapy (FOLFIRI) for hepatic metastases from colorectal cancer: final results of a phase III study.
Giammaria Fiorentini, Camillo Aliberti, Massimo Tilli et al. · PubMed · 2012 · 331 citations
Comparison Between Hepatic Wedge Resection and Anatomic Resection for Colorectal Liver Metastases
Daria Zorzi, John T. Mullen, Eddie K. Abdalla et al. · Journal of Gastrointestinal Surgery · 2005 · 171 citations
Surgical Oncology, Hepatology, Colorectal Liver Metastases +11